Biomedical/Medical Engineering at Alfred University

Borrowing $26,000 for a biomedical engineering degree sounds manageable when peer programs in New York suggest first-year earnings around $62,600—a debt-to-earnings ratio of 0.42 that's well within the range most financial advisors consider sustainable. Similar programs across New York typically produce debt closer to $22,800, so Alfred's estimated burden runs slightly higher, but not alarmingly so given that engineering graduates generally command salaries that can absorb this difference.

The challenge is context. New York's biomedical engineering landscape is dominated by research powerhouses like Rensselaer and Rochester, where reported first-year earnings exceed $72,000. Those premium outcomes reflect both stronger industry connections and more competitive student bodies (Alfred's 1205 average SAT trails well behind these flagships). When comparable programs suggest earnings around $62,600—roughly $10,000 below what top New York programs deliver—you're looking at a meaningful gap that compounds over a career.

For families without unlimited resources (and with 39% of Alfred students on Pell grants, many don't), the core question is whether Alfred's smaller engineering program offers enough differentiation—whether through hands-on research, faculty mentorship, or graduate school placement—to justify similar debt loads as programs with demonstrably stronger market outcomes. Without actual graduate data from Alfred itself, you're making this investment based on what typical New York biomedical programs deliver, not on this specific school's track record.